Innova
Rx
Innova Health Strategies
Search
Index
Browse
Meds
Risk score
Pricing
Sign in
Code set
FY2027
FY2026
FY2025
FY2024
Go
Light
System
Dark
/
Medications
›
antihemophilic factor (recombinant) pegylated
antihemophilic factor (recombinant) pegylated
RxCUI 1741397
precise ingredient
Contraindicated with · 5
Chemically-Induced Disorders
Disease
Diseases, Life Phases, Behavior Mechanisms and Physiologic States
Drug Hypersensitivity
Drug-Related Side Effects and Adverse Reactions
Indicated for · 17
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Blood Platelet Disorders
Coagulation Protein Disorders
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Disease
Diseases, Life Phases, Behavior Mechanisms and Physiologic States
Factor VII Deficiency
Genetic Diseases, Inborn
Hematologic Diseases
Hemic and Lymphatic Diseases
Hemophilia A
Hemorrhage
Hemorrhagic Disorders
Pathological Conditions, Signs and Symptoms
Pathologic Processes
von Willebrand Diseases
Indicated to prevent · 5
Disease
Diseases, Life Phases, Behavior Mechanisms and Physiologic States
Hemorrhage
Pathological Conditions, Signs and Symptoms
Pathologic Processes
